Intense regulatory demands, cost pressure, and the need to be ever more efficient has led to an upturn in the use of management consultants in the pharma & biotech sector, writes B.J. Richards.
B.J. Richards
Advertisement
B.J. Richards is Senior Editor, Source Global Research (Source).
Articles by B.J. Richards
Advertisement
Latest Updated Articles
- Making the Most of Management Consulting
Published: March 28th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
2
Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL
3
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
4
Is FDA Streamlining Regulations in the Biosimilar Space?
5
